Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

@article{Khan2007PrognosticVO,
  title={Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.},
  author={Sohail Q. Khan and Russell J O'brien and Joachim Struck and Paulene A. Quinn and Nils G. Morgenthaler and Iain B Squire and Joan E. Davies and Andreas Bergmann and Leong Loke Ng},
  journal={Journal of the American College of Cardiology},
  year={2007},
  volume={49 14},
  pages={1525-32}
}
OBJECTIVES This study sought to assess the prognostic impact of midregional pro-adrenomedullin (MR-proADM) after an acute myocardial infarction (AMI). BACKGROUND Adrenomedullin (ADM) is elevated in heart failure (HF) and after AMI. Another part of its precursor, MR-proADM, is more stable in circulation and ex vivo. We investigated the cardiovascular prognostic value after AMI of MR-proADM and compared it with N-terminal pro-B-type natriuretic peptide (NTproBNP), a marker of death and HF… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

Prognostic value of PCT, copeptin, MR-proADM, MR-proANP and CT-proET-1 for severe acute dyspnea in the emergency department: the BIODINER study.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Prognostic value of N - terminal pro - atrial and pro - brain natriuretic peptide in patients with acute coronary syndromes

T Omland, JA deLemos, DA Morrow
Am J Cardiol • 2002

Similar Papers

Loading similar papers…